Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/20/2021 13 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 10 0
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/19/2021 8 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/19/2021 38 37
Remdesivir Approved by FDA Experimental Antiviral Jan/19/2021 49 4
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 28 3
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 5 0
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 6 0